Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Sees Significant Decrease in Short Interest

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the recipient of a significant decrease in short interest in February. As of February 15th, there was short interest totalling 400 shares, a decrease of 89.5% from the January 31st total of 3,800 shares. Based on an average daily volume of 5,400 shares, the short-interest ratio is currently 0.1 days.

Fidelity Disruptive Medicine ETF Price Performance

FMED stock traded down $0.06 during trading hours on Friday, reaching $24.93. The stock had a trading volume of 1,993 shares, compared to its average volume of 5,459. The stock has a market capitalization of $52.36 million, a PE ratio of 43.85 and a beta of 0.94. The stock has a 50-day simple moving average of $25.64 and a 200 day simple moving average of $25.78. Fidelity Disruptive Medicine ETF has a fifty-two week low of $23.32 and a fifty-two week high of $26.79.

Fidelity Disruptive Medicine ETF Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 24th. Shareholders of record on Friday, December 20th were issued a $0.112 dividend. This is a positive change from Fidelity Disruptive Medicine ETF’s previous quarterly dividend of $0.00. This represents a $0.45 annualized dividend and a yield of 1.80%. The ex-dividend date of this dividend was Friday, December 20th.

Hedge Funds Weigh In On Fidelity Disruptive Medicine ETF

An institutional investor recently raised its position in Fidelity Disruptive Medicine ETF stock. Jane Street Group LLC raised its position in Fidelity Disruptive Medicine ETF (NASDAQ:FMED) by 7.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 65,883 shares of the company’s stock after buying an additional 4,541 shares during the quarter. Jane Street Group LLC owned about 3.14% of Fidelity Disruptive Medicine ETF worth $1,625,000 at the end of the most recent quarter.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.